Lorlatinib

Overview

Lorlatinib is an ATP-competitive ROS1/ALK inhibitor with potential antitumor activity. Lorlatinib binds to both ALK and ROS1 kinases, resulting in disruption of ALK- and ROS1-mediated signaling and inhibition of ALK- and ROS1-overexpressing tumor cells.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | ALK

Product Information

• Catalog No.: B0084-462453
• CAS No.: 1454846-35-5
• Molecular Formula: C21H19FN6O2
• Molecular Weight: 406.421
• Purity: ≥98%

Source

Original product source